Topic - Indivior

Related Stories

Newly-released inmate George Ballentine holds his prescription medicine Suboxone outside a pharmacy on July 23, 2018, in Greenfield, Mass. The attorneys general for 41 states and the District of Columbia announced a $102.5 million settlement Friday, June 2, 2023, with Suboxone maker Indivior Inc., over claims that the company schemed to keep generic competitors off the market. Suboxone, a branded version of buprenorphine and naloxone, is used to treat opioid addiction. (AP Photo/Elise Amendola) **FILE**

Maker of anti-addiction drug Suboxone reaches $102.5 million settlement over antitrust claims

Associated Press

South Dakota receives $33,000 in pharmaceutical settlement

Associated Press

Anti-opioid addiction drug maker charged with fraud

By ALAN SUDERMAN - Associated Press

Illustration on the opioid crisis by Linas Garsys/The Washington Times

How drug companies keep their prices high and lock competitors out of the market

By Bob Barr

US approves monthly injection for opioid addiction

By MATTHEW PERRONE - Associated Press

Maryland joins suit against drug maker as overdoses rise

By SAM REILLY - Associated Press